Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...

Armed with some Python and a white-hot sense of injustice, one medical student spent six months trying to figure out whether ...

Despite decades of research showing that traditional interviews are only moderately reliable predictors of performance, organizations continue to rely on them heavily. In fact, the typical interview ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Snowflake CEO Sridhar Ramaswamy said he values drive and malleability in job candidates. He said that he asks candidates about what they have changed in their personal lives. Tech CEOs are ...

There's one job interview question that you can almost guarantee hiring managers will ask that many people still struggle to answer. That's because there really is no clear angle. Still, if you're ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Stumped by small talk? Here are dozens of interesting questions to ask when you want to unlock deeper conversations, form closer connections and maybe even elicit some shocking confessions. Whether ...

Four New York Times reporters pressed Mr. Trump about a range of topics in a nearly two-hour interview. Here is a transcript of their conversation. President Trump spoke to four New York Times ...

Recursion Pharmaceuticals utilizes a proprietary operating system (OS) and an AI-powered algorithm that continuously runs virtual experiments, testing compounds against a library of human genes to ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...